In a study by Dr. Jean-Yves Douillard of the Centre Rene Gauducheau in St. Herblain, France, and colleagues in Italy and Spain, researchers found that adding a course of radiation to chemotherapy doubled the lives of some lung cancer patients.
The survey tested 840 patients with stage three lung cancer, which had spread to lymph nodes outside the lung, but not throughout the body. Of these, 232 agreed to extra radiation treatment.
The treatment doubled survival for some, but not all of the patients, Douillard announced at ASTRO. Among patients whose non-small cell lung cancer had spread to mediastinal lymph nodes, radiation therapy helped them live almost two years longer than those patients who had only chemotherapy after surgery.
But in patients where the disease had not spread as far, researchers found that adding the radiation therapy appeared to shorten their remaining life span.
“The results show that radiation treatment should be considered for resected (surgically treated) non-small cell lung cancer with involved mediastinal lymph nodes in addition to chemotherapy,” said Douillard.


Additional Content

Feature | Artificial Intelligence | Kyle Hardner

A radiologist pulls up a chest CT scan flagged for a pulmonary nodule. One artificial intelligence (AI) tool writes its ...

Time September 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Could the era of the empowered patient change how imaging reports are structured and presented? It’s a question on the ...

Time August 03, 2026
arrow
News | PACS

July 8, 2026 — Freeland Systems, a cloud PACS and clinical imaging software company, has launched its new customer ...

Time July 10, 2026
arrow
News | Digital Pathology

June 15, 2026 — Leica Biosystems is expanding the availability of its Aperio GT Elite digital scanner into the EMEA ...

Time June 15, 2026
arrow
News | Imaging Software Development

June 10, 2026 — DeepHealth, Inc., a wholly owned subsidiary of RadNet, has launched Reporting Pro, an AI-powered ...

Time June 12, 2026
arrow
Subscribe Now